Daniel Gross, MD
Procedural Dermatology · Tarzana, CANPI 1396740056
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 37 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 18 manufacturers, the largest accounting for just 13.6% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $853 and has fallen 93.0% since, to $60 in 2024. That places this record below the midpoint for procedural dermatology clinicians in CA, where the typical reported total is $2,566.
Across 37 payments — averaging $48.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Regeneron Healthcare Solutions, Inc.$244
- Sun Pharmaceutical Industries Inc.$229
- E.r. Squibb & Sons, L.L.C.$177
- AbbVie$170
- Biofrontera Inc.$157
- Dermira, Inc.$125
- plus $695 from 12 others
What the payments were for
- Food & beverage$1,796100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 2 | $244 |
| Sun Pharmaceutical Industries Inc. | 4 | $229 |
| E.r. Squibb & Sons, L.L.C. | 2 | $177 |
| AbbVie | 3 | $170 |
| Biofrontera Inc. | 2 | $157 |
| Dermira, Inc. | 1 | $125 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 2 | $121 |
| Pfizer | 1 | $81 |
| Cardiovascular Systems Inc. | 1 | $81 |
| Johnson & Johnson | 4 | $74 |
| Novartis | 4 | $70 |
| Lilly USA, LLC | 3 | $70 |
| Amgen | 2 | $56 |
| Bristol Myers Squibb | 1 | $51 |
| Genentech USA, Inc. | 2 | $37 |
| DUSA Pharmaceuticals, Inc. | 1 | $22 |
| Incyte Corporation | 1 | $21 |
| Prugen, Inc. Pharmaceuticals | 1 | $10 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,796 in reported general payments places this provider in the 45th percentile of 108 procedural dermatology providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Fluorouracil | 38 | $2,523 |
| ValacyclovirValacyclovir Hcl | 22 | $1,991 |
| Clobetasol Propionate | 24 | $1,975 |
| Tretinoin | 12 | $1,103 |
| Doxycycline Hyclate | 31 | $840 |
| Triamcinolone Acetonide | 65 | $367 |
| Metronidazole | 11 | $347 |
| Mupirocin | 25 | $196 |
Paid to pharmacies, not to this prescriber.
Other procedural dermatology in Tarzana
- Sam Khalifianla Mesa$3.5M
- Sabrina FabiSan Diego$3.1M
- Natasha MesinkovskaMission Viejo$499K
- Jeanette BlackLos Angeles$492K
- Mitchel GoldmanSan Diego$425K
- Rebecca FitzgeraldLos Angeles$230K
- Suzanne KilmerSacramento$220K
- Zakia RahmanStanford$181K
- Hrak JalianSanta Monica$160K
- Amelia HausauerCampbell$117K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.